Mi Shao

642 total citations
16 papers, 242 citations indexed

About

Mi Shao is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Mi Shao has authored 16 papers receiving a total of 242 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Mi Shao's work include CAR-T cell therapy research (12 papers), Immune Cell Function and Interaction (3 papers) and CRISPR and Genetic Engineering (2 papers). Mi Shao is often cited by papers focused on CAR-T cell therapy research (12 papers), Immune Cell Function and Interaction (3 papers) and CRISPR and Genetic Engineering (2 papers). Mi Shao collaborates with scholars based in China, India and United States. Mi Shao's co-authors include He Huang, Xinyi Teng, Pengxu Qian, Yue Huang, Xiaohui Si, Xia Li, Xiangjun Zeng, Gang Xiao, Jiazhen Cui and Yongxian Hu and has published in prestigious journals such as Blood, Cancer Research and Advanced Science.

In The Last Decade

Mi Shao

12 papers receiving 241 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mi Shao China	7	162	92	74	59	43	16	242
Tommaso Sconocchia Austria	10	116 0.7×	91 1.0×	86 1.2×	43 0.7×	22 0.5×	20	252
Xiaoqian Liang China	6	243 1.5×	98 1.1×	117 1.6×	54 0.9×	68 1.6×	8	334
Ko Kudo Japan	6	160 1.0×	53 0.6×	76 1.0×	83 1.4×	57 1.3×	25	227
Pierre Sesques France	10	259 1.6×	55 0.6×	60 0.8×	32 0.5×	46 1.1×	27	359
Brianna Flynn United States	6	223 1.4×	103 1.1×	94 1.3×	65 1.1×	49 1.1×	10	277
Rebecca Epperly United States	7	171 1.1×	72 0.8×	83 1.1×	29 0.5×	59 1.4×	30	241
Monalisa Ghosh United States	9	170 1.0×	63 0.7×	87 1.2×	56 0.9×	26 0.6×	45	308
Nisha Ghatwai United States	4	184 1.1×	131 1.4×	48 0.6×	36 0.6×	39 0.9×	4	262
Aleksei Titov Russia	7	214 1.3×	147 1.6×	122 1.6×	61 1.0×	70 1.6×	13	368
Houli Zhao China	10	275 1.7×	66 0.7×	100 1.4×	50 0.8×	75 1.7×	24	338

Countries citing papers authored by Mi Shao

Since Specialization

Citations

This map shows the geographic impact of Mi Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi Shao more than expected).

Fields of papers citing papers by Mi Shao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mi Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi Shao. The network helps show where Mi Shao may publish in the future.

Co-authorship network of co-authors of Mi Shao

This figure shows the co-authorship network connecting the top 25 collaborators of Mi Shao. A scholar is included among the top collaborators of Mi Shao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mi Shao. Mi Shao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Shao, Mi, et al.. (2024). Unraveling the roles and mechanisms of mitochondrial translation in normal and malignant hematopoiesis. Journal of Hematology & Oncology. 17(1). 95–95. 2 indexed citations

Huang, Yue, Mi Shao, Xinyi Teng, et al.. (2024). Inhibition of CD38 enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism. Cell Reports Medicine. 5(2). 101400–101400. 31 indexed citations

Guo, Xin, Xinyi Teng, Mi Shao, et al.. (2023). Post-Transcriptional Features of CAR-T Cell Excessively Activated By Tonic Signaling. Blood. 142(Supplement 1). 6832–6832.

Teng, Xinyi, Mi Shao, Xin Guo, et al.. (2023). Autophagy Inhibition Prevents CAR-T Exhaustion and Terminal Differentiation Via TCF7 Accumulation. Blood. 142(Supplement 1). 4823–4823. 1 indexed citations

Huang, Yue, Xiaohui Si, Mi Shao, et al.. (2022). Rewiring mitochondrial metabolism to counteract exhaustion of CAR-T cells. Journal of Hematology & Oncology. 15(1). 38–38. 60 indexed citations

Wang, Yiyun, et al.. (2022). Off-the-Shelf, Multiplexed-Engineered iPSC-Derived CD33 CAR-NK Cells for Treatment of Acute Myeloid Leukemia. Blood. 140(Supplement 1). 12685–12685. 7 indexed citations

Shao, Mi, Xinyi Teng, Xin Guo, et al.. (2022). Inhibition of Calcium Signaling Prevents Exhaustion and Enhances Anti‐Leukemia Efficacy of CAR‐T Cells via SOCE‐Calcineurin‐NFAT and Glycolysis Pathways. Advanced Science. 9(9). e2103508–e2103508. 44 indexed citations

Wang, Yiyun, et al.. (2022). Abstract 3155: "Super NK cells" - natural killer cells derived from engineered hiPSC with enhanced NK receptor expression demonstrate better anti-tumor effects for solid tumors. Cancer Research. 82(12_Supplement). 3155–3155.

Zeng, Xiangjun, Xia Li, Mi Shao, et al.. (2021). Integrated Single-Cell Bioinformatics Analysis Reveals Intrinsic and Extrinsic Biological Characteristics of Hematopoietic Stem Cell Aging. Frontiers in Genetics. 12. 745786–745786. 4 indexed citations

10.

Shao, Mi, Qin Yu, Xinyi Teng, et al.. (2021). CRS-related coagulopathy in BCMA targeted CAR-T therapy: a retrospective analysis in a phase I/II clinical trial. Bone Marrow Transplantation. 56(7). 1642–1650. 24 indexed citations

11.

Li, Xia, Mi Shao, Xiangjun Zeng, Pengxu Qian, & He Huang. (2021). Signaling pathways in the regulation of cytokine release syndrome in human diseases and intervention therapy. Signal Transduction and Targeted Therapy. 6(1). 367–367. 53 indexed citations

12.

Liang, Zuyu, Hao Zhang, Mi Shao, et al.. (2020). Lymphodepletion chemotherapy revitalizes chimeric antigen receptor T cells contributing to regression of relapsed B-cell lymphoma. Medicine. 99(43). e22510–e22510. 8 indexed citations

13.

Teng, Xinyi, Hao Zhang, Zuyu Liang, et al.. (2019). Galectin-9 from Bone Marrow Mesenchymal Stromal Cells Mediates Immunosuppression on Chimeric Antigen Receptor T Cells. Blood. 134(Supplement_1). 5609–5609. 3 indexed citations

14.

Hu, Yongxian, Jingjing Feng, Mi Shao, & He Huang. (2018). Profile of Capillary-Leak Syndrome in Patients Received Chimeric Antigen Receptor T Cell Therapy. Blood. 132(Supplement 1). 5204–5204. 5 indexed citations

15.

Zeng, Zhaohua & Mi Shao. (2018). Impact of EVM on Network Performance. 13–16.

16.

Shao, Mi, Donghua He, & Zhen Cai. (2018). [Advances on PD-1/PD-L1 inhibitors in multiple myeloma].. PubMed. 39(3). 261–264.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact